Skip to main content
. 2019 May 7;38(8):845–855. doi: 10.1016/j.healun.2019.05.001

Figure 5.

Figure 5

Kaplan–Meier estimates of chronic lung allograft dysfunction (CLAD)-free survival in the 1 year following biopsy. (a) Comparison of CLAD-free survival following the bronchoscopy procedure for patients with or without acute cellular rejection (ACR) histopathology. (b) Comparison of CLAD-free survival following the bronchoscopy procedure for patients classified as ACR or no ACR by the genomic classifier model. BAL, bronchoalveolar lavage.